<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Of 25 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease seen in five years at the Mayo Clinic, seven had central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement </plain></SENT>
<SENT sid="1" pm="."><plain>The mean interval from <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease to central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement was 1.3 years, and the mean period of observation thereafter was 3.8 years </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had <z:hpo ids='HP_0002315'>headache</z:hpo> and <z:hpo ids='HP_0001945'>fever</z:hpo> during or preceding exacerbations of the central <z:mp ids='MP_0008912'>nervous</z:mp> system disease, and <z:hpo ids='HP_0000001'>all</z:hpo> had cerebrospinal fluid pleocytosis (white cell counts ranged from 6 to 490/mm3) with predominant <z:hpo ids='HP_0100827'>lymphocytosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The mean cerebrospinal fluid protein level was 55 mg/dl, and gamma globulin was less than 15 per cent in six patients </plain></SENT>
<SENT sid="4" pm="."><plain>Results of cerebrospinal fluid, lesional and serologic studies for <z:mp ids='MP_0001794'>bacterial</z:mp>, fungal and <z:mp ids='MP_0001799'>viral</z:mp> agents were negative </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical findings included corticospinal tract disease (five patients), <z:hpo ids='HP_0001251'>cerebellar ataxia</z:hpo> (four patients), <z:hpo ids='HP_0007024'>pseudobulbar palsy</z:hpo> (three patients) and transient ocular palsies (three patients) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these occurred in concert with the systemic phases, especially <z:e sem="disease" ids="C0016514" disease_type="Disease or Syndrome" abbrv="">aphthosis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="50858">Corticosteroid</z:chebi> therapy was used in six patients, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> therapy in two and <z:chebi fb="2" ids="2948">azathioprine</z:chebi> therapy in two </plain></SENT>
<SENT sid="8" pm="."><plain>The neurologic manifestations tended to recur when dosages of the drugs were lowered and established central <z:mp ids='MP_0008912'>nervous</z:mp> system damage could not be reversed </plain></SENT>
<SENT sid="9" pm="."><plain>The case histories suggest that steroids, when used promptly and in sufficient dosage (up to 60 mg <z:chebi fb="0" ids="8382">prednisone</z:chebi>), are effective in reducing or preventing progression of central <z:mp ids='MP_0008912'>nervous</z:mp> system disease </plain></SENT>
<SENT sid="10" pm="."><plain>Three patients died, one from <z:e sem="disease" ids="C0851886" disease_type="Disease or Syndrome" abbrv="">Pneumocystis carinii infection</z:e>, one from neurologic disease and another from presumed <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease should be diagnosed earlier, and it can be if attention is given to other systemic criteria, that is, aphthous <z:hpo ids='HP_0010280'>stomatitis</z:hpo>, aphthous <z:e sem="disease" ids="C0744369" disease_type="Disease or Syndrome" abbrv="">genital lesions</z:e>, cutaneous <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, <z:hpo ids='HP_0000554'>uveitis</z:hpo> and <z:hpo ids='HP_0100769'>synovitis</z:hpo> </plain></SENT>
</text></document>